clonidine has been researched along with cysteine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Imai, S; Kitamura, Y; Matsueda, R; Nomura, Y | 1 |
Bogin, E; Levi, Y; Marom, M | 1 |
Cockcroft, V; Heinonen, P; Marjamaki, A; Pihlavisto, M; Savola, JM; Scheinin, M | 1 |
Bahia, DS; Jackson, VN; Milligan, G | 1 |
Frang, H; Hoffrén, AM; Javitch, JA; Johnson, MS; Kallio, J; Marjamäki, A; Pihlavisto, M; Salminen, T; Scheinin, M | 1 |
1 review(s) available for clonidine and cysteine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for clonidine and cysteine
Article | Year |
---|---|
Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Cell Membrane; Clonidine; Cysteine; Ethylmaleimide; GTP-Binding Proteins; Guanosine Triphosphate; Indicators and Reagents; Male; Nitro Compounds; Pertussis Toxin; Pyridines; Rats; Receptors, Adrenergic, alpha; Receptors, Serotonin; Sulfhydryl Compounds; Tetrahydronaphthalenes; Virulence Factors, Bordetella | 1990 |
Changes in serum, liver and kidneys of cisplatin-treated rats; effects of antioxidants.
Topics: Animals; Antioxidants; Blood Proteins; Cisplatin; Clonidine; Cysteine; Drug Interactions; Erythrocytes; Glutathione Reductase; Isocitrate Dehydrogenase; Kidney; Kidney Diseases; Liver; Male; Mitochondria; Oxidation-Reduction; Phosphorylation; Rats; Rats, Sprague-Dawley; Vitamin E | 1994 |
Chloroethylclonidine binds irreversibly to exposed cysteines in the fifth membrane-spanning domain of the human alpha2A-adrenergic receptor.
Topics: Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; Binding Sites; Clonidine; Cysteine; Humans; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Structure, Secondary; Rats; Receptors, Adrenergic, alpha-2; Structure-Activity Relationship; Transfection | 1998 |
Modulation of relative intrinsic activity of agonists at the alpha-2A adrenoceptor by mutation of residue 351 of G protein gi1alpha.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Clonidine; COS Cells; Cysteine; Dose-Response Relationship, Drug; Epinephrine; Glycine; GTP Phosphohydrolases; GTP-Binding Protein alpha Subunits, Gi-Go; Point Mutation; Quinoxalines; Radioligand Assay; Receptors, Adrenergic, alpha-2; Recombinant Fusion Proteins; Swine; Yohimbine | 1999 |
Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human alpha(2A)-adrenergic receptor.
Topics: Adrenergic alpha-Antagonists; Amino Acid Substitution; Animals; Binding Sites; CHO Cells; Clonidine; Cricetinae; Cysteine; Ethyl Methanesulfonate; Humans; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Protein Conformation; Protein Structure, Secondary; Receptors, Adrenergic, alpha-2; Recombinant Proteins; Thermodynamics; Transfection | 1999 |